Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,517 | -22,997 | -16,993 | -9,279 | -3,263 |
| Depreciation Amortization | 165 | 864 | 698 | 531 | 282 |
| Accounts receivable | 11 | 121 | -272 | -333 | -60 |
| Other Working Capital | 740 | 1,705 | 1,767 | -123 | -295 |
| Other Operating Activity | 141 | 740 | -97 | -1,169 | -1,608 |
| Operating Cash Flow | $-6,460 | $-19,567 | $-14,897 | $-10,373 | $-4,944 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,384 | -47,563 | -15,365 | -15,300 | N/A |
| PPE Investments | -137 | -279 | -251 | -205 | -83 |
| Investing Cash Flow | $9,247 | $-47,842 | $-15,616 | $-15,505 | $-83 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 174 | 23,964 | 23,916 | 82 | 44 |
| Financing Cash Flow | $174 | $23,964 | $23,916 | $82 | $44 |
| Exchange Rate Effect | 104 | 1,889 | 2,081 | 2,355 | 2,396 |
| Beginning Cash Position | 17,095 | 58,651 | 58,651 | 58,651 | 58,651 |
| End Cash Position | 20,160 | 17,095 | 54,135 | 35,210 | 56,064 |
| Net Cash Flow | $3,065 | $-41,556 | $-4,516 | $-23,441 | $-2,587 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,460 | -19,567 | -14,897 | -10,373 | -4,944 |
| Capital Expenditure | -137 | -279 | -251 | -205 | -83 |
| Free Cash Flow | -6,597 | -19,846 | -15,148 | -10,578 | -5,027 |